Skip to main content
Erschienen in: Lung 6/2011

01.12.2011

Clinical Characteristics and Prognosis of Nontuberculous Mycobacterial Lung Disease with Different Radiographic Patterns

verfasst von: Chin-Chung Shu, Chih-Hsin Lee, Chia-Lin Hsu, Jann-Tay Wang, Jann-Yuan Wang, Chong-Jen Yu, Li-Na Lee, The TAMI Group

Erschienen in: Lung | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Rationale

The clinical characteristics and prognostic impact of radiographic patterns of patients with nontuberculous mycobacterial lung disease (NTM-LD) are rarely evaluated.

Design

Patients with NTM-LD from 2007 to 2009 in a single medical center in Taiwan were identified. Their radiographic patterns were reviewed and classified into cavitary, bronchiectatic, or consolidative. They were also compared to patients with cavitary pulmonary tuberculosis (TB-LD).

Results

Of 481 NTM-LD patients identified, 62, 134, and 56 patients were categorized into cavitary, bronchiectatic, and consolidative groups, respectively. Compared with 180 TB-LD patients, cavitary NTM-LD had male predominance and was associated with higher grades of sputum acid-fast smear (3+ or 4+), prior pulmonary TB, and poor baseline pulmonary function. NTM-LD patients with consolidative pattern were likely to have underlying comorbidity, the highest blood leukocyte count and C-reactive protein, and lowest albumin. In all NTM-LD, the consolidative pattern was independently associated with poor prognosis for 6-month survival. Patients with cavitary Mycobacterium avium complex (MAC)-LD had worse 6-month survival than those with bronchiectatic pattern.

Conclusion

In Taiwan, NTM-LD patients with consolidative pattern have the worst prognosis while patients with cavitary pattern have worse survival than those with bronchiectasis in MAC-LD. Because varying radiographic patterns represent different prognoses, understanding the characteristics of NTM-LD patients with different radiographic patterns complements clinical practice.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Lai CC, Tan CK, Chou CH et al (2010) Increasing incidence of non-tuberculous mycobacteria, Taiwan, 2000–2008. Emerg Infect Dis 16(2):294–296PubMed Lai CC, Tan CK, Chou CH et al (2010) Increasing incidence of non-tuberculous mycobacteria, Taiwan, 2000–2008. Emerg Infect Dis 16(2):294–296PubMed
2.
Zurück zum Zitat Field SK, Cowie RL (2006) Lung disease due to the more common non-tuberculous mycobacteria. Chest 129(6):1653–1672PubMedCrossRef Field SK, Cowie RL (2006) Lung disease due to the more common non-tuberculous mycobacteria. Chest 129(6):1653–1672PubMedCrossRef
3.
Zurück zum Zitat Griffith DE, Aksamit T, Brown-Elliott BA et al (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of non-tuberculous mycobacterial diseases. Am J Respir Crit Care Med 175(4):367–416PubMedCrossRef Griffith DE, Aksamit T, Brown-Elliott BA et al (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of non-tuberculous mycobacterial diseases. Am J Respir Crit Care Med 175(4):367–416PubMedCrossRef
4.
Zurück zum Zitat Chetchotisakd P, Kiertiburanakul S, Mootsikapun P, Assanasen S, Chaiwarith R, Anunnatsiri S (2007) Disseminated non-tuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. Clin Infect Dis 45(4):421–427PubMedCrossRef Chetchotisakd P, Kiertiburanakul S, Mootsikapun P, Assanasen S, Chaiwarith R, Anunnatsiri S (2007) Disseminated non-tuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. Clin Infect Dis 45(4):421–427PubMedCrossRef
5.
Zurück zum Zitat Martin-Casabona N, Bahrmand AR, Bennedsen J et al (2004) Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis 8(10):1186–1193PubMed Martin-Casabona N, Bahrmand AR, Bennedsen J et al (2004) Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis 8(10):1186–1193PubMed
6.
Zurück zum Zitat Shu CC, Lee CH, Wang JY et al (2008) Nontuberculous mycobacteria pulmonary infection in medical intensive care unit: the incidence, patient characteristics, and clinical significance. Intensive Care Med 34(12):2194–2201PubMedCrossRef Shu CC, Lee CH, Wang JY et al (2008) Nontuberculous mycobacteria pulmonary infection in medical intensive care unit: the incidence, patient characteristics, and clinical significance. Intensive Care Med 34(12):2194–2201PubMedCrossRef
7.
Zurück zum Zitat Donnabella V, Salazar-Schicchi J, Bonk S, Hanna B, Rom WN (2000) Increasing incidence of Mycobacterium xenopi at Bellevue Hospital: an emerging pathogen or a product of improved laboratory methods? Chest 118(5):1365–1370PubMedCrossRef Donnabella V, Salazar-Schicchi J, Bonk S, Hanna B, Rom WN (2000) Increasing incidence of Mycobacterium xenopi at Bellevue Hospital: an emerging pathogen or a product of improved laboratory methods? Chest 118(5):1365–1370PubMedCrossRef
8.
Zurück zum Zitat Lu D, Heeren B, Dunne WM (2002) Comparison of the Automated Mycobacteria Growth Indicator Tube System (BACTEC 960/MGIT) with Lowenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Am J Clin Pathol 118(4):542–545PubMedCrossRef Lu D, Heeren B, Dunne WM (2002) Comparison of the Automated Mycobacteria Growth Indicator Tube System (BACTEC 960/MGIT) with Lowenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Am J Clin Pathol 118(4):542–545PubMedCrossRef
9.
Zurück zum Zitat Koh WJ, Yu CM, Suh GY et al (2006) Pulmonary TB and NTM lung disease: comparison of characteristics in patients with AFB smear-positive sputum. Int J Tuberc Lung Dis 10(9):1001–1007PubMed Koh WJ, Yu CM, Suh GY et al (2006) Pulmonary TB and NTM lung disease: comparison of characteristics in patients with AFB smear-positive sputum. Int J Tuberc Lung Dis 10(9):1001–1007PubMed
10.
Zurück zum Zitat Obayashi Y, Fujita J, Suemitsu I, Kamei T, Nii M, Takahara J (1998) Clinical features of non-tuberculous mycobacterial disease: comparisons between smear-positive and smear-negative cases, and between Mycobacterium avium and Mycobacterium intracellulare. Int J Tuberc Lung Dis 2(7):597–602PubMed Obayashi Y, Fujita J, Suemitsu I, Kamei T, Nii M, Takahara J (1998) Clinical features of non-tuberculous mycobacterial disease: comparisons between smear-positive and smear-negative cases, and between Mycobacterium avium and Mycobacterium intracellulare. Int J Tuberc Lung Dis 2(7):597–602PubMed
11.
Zurück zum Zitat The Research Committee of the British Thoracic Society (2002) Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment. Int J Tuberc Lung Dis 6(7):628–634 The Research Committee of the British Thoracic Society (2002) Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment. Int J Tuberc Lung Dis 6(7):628–634
12.
Zurück zum Zitat Wang JY, Hsueh PR, Wang SK et al (2007) Disseminated tuberculosis: a 10-year experience in a medical center. Medicine 86(1):39–46PubMedCrossRef Wang JY, Hsueh PR, Wang SK et al (2007) Disseminated tuberculosis: a 10-year experience in a medical center. Medicine 86(1):39–46PubMedCrossRef
13.
Zurück zum Zitat Pfyffer GE, Vicent V, Gutiérrez MC, Brown-Elliott BA, Wallace RJ (2007) Myobacterium. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Landry ML (eds) Manual of clinical microbiology, 6th edn. American Society for Microbiology, Washington, DC, pp 543–600 Pfyffer GE, Vicent V, Gutiérrez MC, Brown-Elliott BA, Wallace RJ (2007) Myobacterium. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Landry ML (eds) Manual of clinical microbiology, 6th edn. American Society for Microbiology, Washington, DC, pp 543–600
14.
Zurück zum Zitat American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America (2005) American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States. Am J Respir Crit Care Med 172(9):1169–1227 American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America (2005) American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States. Am J Respir Crit Care Med 172(9):1169–1227
15.
Zurück zum Zitat Ralph AP, Ardian M, Wiguna A et al (2010) A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis. Thorax 65(10):863–869PubMedCrossRef Ralph AP, Ardian M, Wiguna A et al (2010) A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis. Thorax 65(10):863–869PubMedCrossRef
16.
Zurück zum Zitat Iseman MD, Chan ED (2010) Bronchiectasis. In: Mason RJ, Broaddus VC, Martin TR, King TE, Schraufnagel DE, Murray JF, Nadel JA (eds) Murray and Nadel’s textbook of respiratory medicine, 5th edn. Elsevier, New York, pp 1023–1046 Iseman MD, Chan ED (2010) Bronchiectasis. In: Mason RJ, Broaddus VC, Martin TR, King TE, Schraufnagel DE, Murray JF, Nadel JA (eds) Murray and Nadel’s textbook of respiratory medicine, 5th edn. Elsevier, New York, pp 1023–1046
17.
Zurück zum Zitat Godoy MC, Vos PM, Cooperberg PL, Lydell CP, Phillips P, Muller NL (2008) Chest radiographic and CT manifestations of chronic granulomatous disease in adults. Am J Roentgenol 191(5):1570–1575CrossRef Godoy MC, Vos PM, Cooperberg PL, Lydell CP, Phillips P, Muller NL (2008) Chest radiographic and CT manifestations of chronic granulomatous disease in adults. Am J Roentgenol 191(5):1570–1575CrossRef
18.
Zurück zum Zitat Shu CC, Wu HD, Yu MC et al (2010) Use of high-dose inhaled corticosteroids is associated with pulmonary tuberculosis in patients with chronic obstructive pulmonary disease. Medicine (Baltimore) 89(1):53–61CrossRef Shu CC, Wu HD, Yu MC et al (2010) Use of high-dose inhaled corticosteroids is associated with pulmonary tuberculosis in patients with chronic obstructive pulmonary disease. Medicine (Baltimore) 89(1):53–61CrossRef
19.
Zurück zum Zitat Pellegrino R, Viegi G, Brusasco V et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26(5):948–968PubMedCrossRef Pellegrino R, Viegi G, Brusasco V et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26(5):948–968PubMedCrossRef
20.
Zurück zum Zitat Kim RD, Greenberg DE, Ehrmantraut ME et al (2008) Pulmonary non-tuberculous mycobacterial disease: prospective study of a distinct pre-existing syndrome. Am J Respir Crit Care Med 178(10):1066–1074PubMedCrossRef Kim RD, Greenberg DE, Ehrmantraut ME et al (2008) Pulmonary non-tuberculous mycobacterial disease: prospective study of a distinct pre-existing syndrome. Am J Respir Crit Care Med 178(10):1066–1074PubMedCrossRef
21.
Zurück zum Zitat Prevots DR, Shaw PA, Strickland D et al (2010) Non-tuberculous mycobacterial lung disease prevalence at four integrated healthcare delivery systems. Am J Respir Crit Care Med 182(7):970–976PubMedCrossRef Prevots DR, Shaw PA, Strickland D et al (2010) Non-tuberculous mycobacterial lung disease prevalence at four integrated healthcare delivery systems. Am J Respir Crit Care Med 182(7):970–976PubMedCrossRef
22.
Zurück zum Zitat Sohn H, Kim HJ, Kim JM, Jung Kwon O, Koh WJ, Shin SJ (2009) High virulent clinical isolates of Mycobacterium abscessus from patients with the upper lobe fibrocavitary form of pulmonary disease. Microb Pathog 47(6):321–328PubMedCrossRef Sohn H, Kim HJ, Kim JM, Jung Kwon O, Koh WJ, Shin SJ (2009) High virulent clinical isolates of Mycobacterium abscessus from patients with the upper lobe fibrocavitary form of pulmonary disease. Microb Pathog 47(6):321–328PubMedCrossRef
23.
Zurück zum Zitat Tatano Y, Yasumoto K, Shimizu T et al (2010) Comparative study for the virulence of Mycobacterium avium isolates from patients with nodular-bronchiectasis- and cavitary-type diseases. Eur J Clin Microbiol Infect Dis 29(7):801–806PubMedCrossRef Tatano Y, Yasumoto K, Shimizu T et al (2010) Comparative study for the virulence of Mycobacterium avium isolates from patients with nodular-bronchiectasis- and cavitary-type diseases. Eur J Clin Microbiol Infect Dis 29(7):801–806PubMedCrossRef
24.
Zurück zum Zitat Aksamit TR (2002) Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease. Clin Chest Med 23(3):643–653PubMedCrossRef Aksamit TR (2002) Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease. Clin Chest Med 23(3):643–653PubMedCrossRef
25.
Zurück zum Zitat Okumura M, Iwai K, Ogata H et al (2008) Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease. Intern Med 47(16):1465–1472PubMedCrossRef Okumura M, Iwai K, Ogata H et al (2008) Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease. Intern Med 47(16):1465–1472PubMedCrossRef
26.
Zurück zum Zitat Baig IM, Saeed W, Khalil KF (2010) Post-tuberculous chronic obstructive pulmonary disease. J Coll Physicians Surg Pak 20(8):542–544PubMed Baig IM, Saeed W, Khalil KF (2010) Post-tuberculous chronic obstructive pulmonary disease. J Coll Physicians Surg Pak 20(8):542–544PubMed
27.
Zurück zum Zitat Johnson MM, Waller EA, Leventhal JP (2008) Non-tuberculous mycobacterial pulmonary disease. Curr Opin Pulm Med 14(3):203–210PubMedCrossRef Johnson MM, Waller EA, Leventhal JP (2008) Non-tuberculous mycobacterial pulmonary disease. Curr Opin Pulm Med 14(3):203–210PubMedCrossRef
28.
Zurück zum Zitat Koh WJ, Kwon OJ, Jeon K et al (2006) Clinical significance of non-tuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 129(2):341–348PubMedCrossRef Koh WJ, Kwon OJ, Jeon K et al (2006) Clinical significance of non-tuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 129(2):341–348PubMedCrossRef
29.
Zurück zum Zitat Marras TK, Mehta M, Chedore P, May K, Al Houqani M, Jamieson F (2010) Non-tuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics. Lung 188(4):289–299PubMedCrossRef Marras TK, Mehta M, Chedore P, May K, Al Houqani M, Jamieson F (2010) Non-tuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics. Lung 188(4):289–299PubMedCrossRef
30.
Zurück zum Zitat Shu CC, Lee LN, Wang JT, Chien YJ, Wang JY, Yu CJ (2010) Non-tuberculous mycobacterial pleurisy: an 8-year single-centre experience in Taiwan. Int J Tuberc Lung Dis 14(5):635–641PubMed Shu CC, Lee LN, Wang JT, Chien YJ, Wang JY, Yu CJ (2010) Non-tuberculous mycobacterial pleurisy: an 8-year single-centre experience in Taiwan. Int J Tuberc Lung Dis 14(5):635–641PubMed
Metadaten
Titel
Clinical Characteristics and Prognosis of Nontuberculous Mycobacterial Lung Disease with Different Radiographic Patterns
verfasst von
Chin-Chung Shu
Chih-Hsin Lee
Chia-Lin Hsu
Jann-Tay Wang
Jann-Yuan Wang
Chong-Jen Yu
Li-Na Lee
The TAMI Group
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
Lung / Ausgabe 6/2011
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-011-9321-4

Weitere Artikel der Ausgabe 6/2011

Lung 6/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.